Caption Management, LLC Rapt Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$2.89 - $9.38 $2,023 - $6,566	700 New	700 $2,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $23.59 $456,570 - $1.05 Million	44,500 New	44,500 $812,000
Q1 2022 May 13, 2022	SELL	$17.02 - $40.22 $549,746 - $1.3 Million	-32,300 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$29.5 - $39.5 $123,900 - $165,900	-4,200 Reduced 11.51%	32,300 $1.19 Million
Q3 2021 Nov 12, 2021	SELL	$29.86 - $39.47 $7.47 Million - $9.87 Million	-250,100 Reduced 87.26%	36,500 $1.13 Million
Q2 2021 Aug 16, 2021	BUY	$17.99 - $40.02 $5.16 Million - $11.5 Million	286,600 New	286,600 $9.11 Million

103

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $39.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.